We are studying the tumor microenvironment to understand cancer progression and response to therapy. Our goal is to find new ways to treat cancer.
Rudbeck Laboratory, Uppsala
Joined May 2021
- Tweets43
- Following80
- Followers156
- Likes53
DimbergLab retweeted
Our preprint on tertiary lymphoid structures in human brain tumors is online! Joint work with colleagues from @FCI_health @goetheuni Edinger Institute. biorxiv.org/cgi/content/shor…
DimbergLab retweeted
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/SqZ6Kv
DimbergLab retweeted
Read this week's #ResearchWatch:
AAV-Mediated Gene Delivery of LIGHT Prolongs Survival in #Glioblastoma, summarizing the work of @mohanraj9706, @AleVaccaro93, @tiarnevdw, Magnus Essand, @DimbergLab et al.
bit.ly/3q5eQLg
@UU_University
DimbergLab retweeted
Read this week's #ResearchWatch:
AAV-Mediated Gene Delivery of LIGHT Prolongs Survival in #Glioblastoma, summarizing the work of @mohanraj9706, @AleVaccaro93, @tiarnevdw, Magnus Essand, @DimbergLab et al.
bit.ly/3q5eQLg
@UU_University
DimbergLab retweeted
Online Now: Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/Sp6vzN
DimbergLab retweeted
So excited for the next few days at the STorM retreat @STorMSciLifeLab and for meeting the Swedish microenvironment community IRL🤩 Big thanks to @kalyani05v @Milena_kp @JessicaPantal13 and Favour Onyeogaziri for putting together a fantastic program
DimbergLab retweeted
🤩 Mark the dates for upcoming virtual #SSMVR talks!
✅Arndt Siekmann @SiekmannLab
✅Jaap van Buul @VanBuul_lab
✅Anna Dimeberg @DimbergLab
DimbergLab retweeted
BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”
DimbergLab retweeted
The 4th STorM retreat is taking place in Aronsborg Konferenshotell, Stockholm from the 28-30th November 2022!
Register with the below link to enjoy science with excellent keynote speakers and panel discussions! We look forward to meeting you there!
docs.google.com/forms/d/e/1F…
DimbergLab retweeted
If you are interested in B cells check out our new review in @CCR_AACR - thanks for great collab @DoniaMarco and @CCITdk !
B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? clincancerres.aacrjournals.o…
DimbergLab retweeted
ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma - work from @DimbergLab recently published!
Congratulations to all involved! 🍾🥂
academic.oup.com/neuro-oncol…
DimbergLab retweeted
Our article on the effects of agonistic CD40 antibody therapy on glioma and the formation of Tertiary lymphoid structure is published in
@NatureComms
go.nature.com/3qKVzeB
bit.ly/3ws9t6F
Congratulations @AnnaDimberg @LuukvanHooren @AleVaccaro93 @DimbergLab @tiarnevdw
DimbergLab retweeted
Agonistic CD40 therapy modulates the formation of tertiary lymphoid structures in glioma.
nature.com/articles/s41467-0…
#CancerResearch @UU_University @IgpUu @VascBioUpp @AnnaDimberg @DimbergLab @KAWstiftelsen @Cancerfonden @AleVaccaro93 @LuukvanHooren @mohanraj9706 @tiarnevdw
